Yun Huang
banner
hyshu2024.bsky.social
Yun Huang
@hyshu2024.bsky.social
Associate professor in History at Ningbo University, Postdoc at Shanghai University, PhD from CSHHH of the University of Strathclyde. Email: huangyun@nbu.edu.cn. Researchgate: https://www.researchgate.net/profile/Yun-Huang-11
Reposted by Yun Huang
With the sun out, it is the perfect time to do some summer reading! Recommend a must-read book, article, or online exhibit on medial history for your summer stack below. Bonus points if you can include a one-sentence takeaway that made you pause! #SSHMReads #SummerReading #histmed #skystorians
a person is pushing a stack of books on a table and one of the books has the letter t on it
Alt: a person is pushing a stack of books on a table
media.tenor.com
July 11, 2025 at 1:15 PM
Reposted by Yun Huang
I am pleased to announce the open-access publication of the collective volume Modern China in Flux: Networks, Mobility, and Transformation (De Gruyter).

www.degruyter.com/document/doi...
Modern China in Flux
Modern China in Flux heralds a transformative epoch in historical research, spotlighting the innovative methodology of network analysis. As the digital age unfolds, historians encounter both an unpara...
www.degruyter.com
February 21, 2025 at 8:13 AM
Reposted by Yun Huang
CFPs 📣 Knowledge in Use. Practices and Practitioners in the Renaissance and Early Modern Period (14th-17th centuries)
Deadline for abstracts 31 March 2025
#HistSTM #histmed
Call for abstracts | Knowledge in Use. Practices and Practitioners in the Renaissance and Early Modern Period (14th-17th centuries) | Galilæana. Studies in Renaissance and Early Modern Scie...
gal-studies.museogalileo.it
February 20, 2025 at 4:01 PM
Reposted by Yun Huang
The FDA has approved suzetrigine, a groundbreaking non-opioid painkiller that targets pain at its source, offering a safer, addiction-free pain-relief treatment.
First new non-opioid painkiller approved in the US for decades – here’s how it works
The FDA has approved suzetrigine, a groundbreaking non-opioid painkiller that targets pain at its source, offering a safer, addiction-free pain-relief treatment.
tcnv.link
February 6, 2025 at 6:26 AM